Haemonetics
HAE
$83.46
Share price
-1.67%
Change (1 day)
-1.81%
Change (1 year)
Categories
Operating Margin for Haemonetics (HAE)
Operating Margin as of April 2024 (TTM): 12.09%
According to Haemonetics's latest financial reports and stock price the company's current Operating Margin is 12.09%. At the end of 2023 the company had an Operating Margin of 12.10%.
Operating Margin history for Haemonetics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 12.10% | 88.86% |
| 2022 | 6.41% | -23.52% |
| 2021 | 8.38% | -5% |
| 2020 | 8.82% | 15.86% |
| 2019 | 7.61% | 15.36% |
| 2018 | 6.60% | -312.76% |
| 2017 | -3.10% | -47.24% |
| 2016 | -5.88% | -271.66% |
| 2015 | 3.42% | -11.74% |
| 2014 | 3.88% | -30.66% |
| 2013 | 5.59% | -54.51% |
| 2012 | 12.30% | -24.41% |
| 2011 | 16.27% | 29.19% |
| 2010 | 12.59% | -11.43% |
| 2009 | 14.22% | -5.02% |
| 2008 | 14.97% | -6.96% |
| 2007 | 16.09% | -36.82% |
| 2006 | 25.46% | 63.23% |
| 2005 | 15.60% | 24.03% |
| 2004 | 12.58% | 9.78% |
| 2003 | 11.46% | -4.79% |
| 2002 | 12.03% | 104.1% |
| 2001 | 5.90% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 89.25% | 🇺🇸 USA |
 Medtronic MDT | 17.17% | 42.02% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 14.17% | 17.20% | 🇺🇸 USA |
 Baxter BAX | -19.01% | -257.24% | 🇺🇸 USA |
 Becton Dickinson BDX | 9.46% | -21.75% | 🇺🇸 USA |
 Stryker Corporation SYK | 16.21% | 34.08% | 🇺🇸 USA |
 PerkinElmer
PKI | 14.13% | 16.87% | 🇺🇸 USA |
 Cerus CERS | -41.30% | -441.60% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.